https://knoapharma.com/2026/05/01/knoa-pharma-begins-operations-as-a-new-public-health-focused-company-dedicated-to-supporting-patients-and-abating-the-opioid-crisis/ 2026-05-01T19:08:09+00:00 https://knoapharma.com/2026/06/22/knoa-pharma-to-present-pipeline-assets-at-bio-international-convention-2026/ 2026-06-22T13:37:18+00:00 https://knoapharma.com/2026/06/24/knoa-pharma-and-gcar-announce-first-newly-diagnosed-glioblastoma-patient-randomized-in-phase-2-3-gbm-agile-evaluation-of-tinostamustine-and-first-recurrent-patient-dosed/ 2026-06-24T13:00:36+00:00 https://knoapharma.com/2026/07/01/knoa-pharma-board-appoints-michael-goettler-as-president-and-chief-executive-officer/ 2026-07-01T18:00:49+00:00 https://knoapharma.com/2026/09/22/knoa-pharma-to-present-pipeline-assets-at-lsx-congress-usa-2026/ 2026-09-22T13:00:51+00:00